Granted Janssen was a much much bigger deal but Genetech have...

Granted Janssen was a much much bigger deal but Genetech have marginally increased the cashflow to company at a less advanced stage.

Janssen went Licensing Agreement - Extension - Expansion - Walk for $2.3m Genentech have gone Research Agreement - Licensing Agreement - Extension for $2.5m.

Also worth noting i guess as a whole Roche / Genrntech have contributed more through earlier and expired agreements in a different area of focus. Roche was alwsys pretty tight on the numbers but i think it was about $500k over 3 years targetting the blood brain barrier & delivery. So i guess you could say $3m in total ?